Latest developments in causes and treatments




GLP-1 Drugs Used to Reduce Cancer, Fight Dementia

GLP-1 agonists such as Ozempic and Wegovy are being tested for their ability to impact cancer rates and slow dementia.

More Studies Show Positive Impacts From GLP-1 Agonist Drugs

A new survey from National Geographic explores many positive outcomes of recent trials with GLP-1 agonist drugs.

Drug Companies “Apathetic” About Testing GLP-1 Drugs to Treat Substance Use Disorders

Early studies of GLP-1 drugs for substance abuse treatment show promise, but drug companies are slow to fund research.

Liraglutide and Semaglutide Show Promise in the Treatment of Opioid Use Disorder and Alcohol Use Disorder

New research indicates that liraglutide, semaglutide, and similar GLP-1 drugs may be effective at reducing cravings for opioids and alcohol.

People Who Stop Taking GLP-1 Drugs Such As Ozempic and Wegovy Rapidly Gain Back Weight

New reporting documents the weight gain when people stop taking GLP-1 drugs such as Ozempic and Wegovy.

A Look at the Year Ahead From AddictionNews

A preview of the coming year, including everything from GLP-1 drugs to ibogaine to apps effective in the treatment of substance use disorders.